Co-Founder at Y Combinator
Startups are fighting complex diseases through targeted therapies and on-demand oncology research. By approaching severe medical challenges with the agile mindset of a technology startup, founders inflict a death of a thousand cuts on complex diseases, creating bespoke research platforms that benefit broader patient populations.
This answer is part of a full interview with Paul Graham, Co-Founder at Y Combinator.
Found this insight valuable? Share it with your network to help others learn from Paul Graham's experience.
Use this answer in your research, article, or academic work
